Preclinical Studies for Stroke

Preclinical drug studies play an important role in the drug development process. Only drugs that have completed preclinical drug studies can successfully enter clinical trials. Ace Neuroscience has decades of experience in providing quality services for the comprehensive evaluation of stroke drug candidates. Our scientists strictly control every aspect of the study to ensure its authenticity, reproducibility, and scientific validity. Our professional and responsible approach is designed only to facilitate the successful development of your stroke drug.

Drug Screening Platform

A well-established drug screening process can accelerate drug discovery. Ace Neuroscience has established different drug screening platforms for stroke drug discovery. Our drug screening platforms are comprehensive, covering high throughput screening, high content imaging technology platforms, as well as target-based, fragment-based drug screening platforms, DNA-encoded library technology, and computer-aided drug design technologies. We have established a comprehensive range of services for different stroke targets or stroke research

Learn more：Stroke Preclinical Assessment